• Fibrinogen Early In Severe Trauma study Update

    18 April 2018 01:30 - 02:30pm - Australia/Sydney


    Trauma is the leading cause of death worldwide in individual's aged 18-39 with data from the WHO suggesting that worldwide almost 6 million deaths every year are directly attributable to trauma. Despite advances in trauma management, a significant proportion of these deaths are still due to haemorrhage. Death can occur early as a result of uncontrollable haemorrhage; in patients where surgical haemorrhage control is achieved subsequent morbidity and mortality can be attributed to effects of massive haemorrhage and large volume blood product transfusion.   This session will provide an update for the Feisty Study - An Australian multi-centre randomised, controlled trial studying the effects of rapid fibrinogen replacement in severely bleeding trauma patients.


    Presenter:Dr James Winearls, Consultant Intensivist, Gold Coast University Hospital, (Chief Investigator).

      Learning outcomes:

    • Improve awareness of the FEISTY study
    • Describe the possible future implications 
  • Feedback form and certificate

    If you attended this webinar, please complete the short feedback form to access your certificate.

    Otherwise, click the box above once you have watched the presentation to mark it as complete. To be eligible for your certificate, you must watch over half the presentation and complete the feedback form to download your certificate.